On June 8th, Innovative Medicines Initiative (IMI) organizes a public event with life sessions about the IMI impact on diabetes. Stakeholders will explore the key challenges in their fields and patients living with T1D & T2D will be sharing their own testimonies. IMI and INNODIA hope to engage IMI stakeholders in a broader discussion on IMI’s impact and ask them for their active participation in this live event. The aim of the event is to demonstrate the successful IMI model of radical collaboration.
Click on the Banner for more Information